Vitaminka reported unconsolidated earnings results for the first half of 2013. For the first half, the company reported net profit edged up to some MKD 35.5 million ($769,820/€577,360) from MKD 35.0 million a year earlier. The company's first-half sales revenues increased to MKD 724.4 billion from MKD 675.8 million a year ago, while operating profit rose to MKD 43.4 million from MKD 42.5 million a year ago.